David Garfinkel, MD
Obstetrics & Gynecology · Morristown, NJNPI 1760476899
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (58.3%), food and beverage and education — rather than concentrated in one kind of arrangement. 28 manufacturers reported payments, led by Celularity Inc. at 58.6% of the total. Reporting peaked in 2019 at $1,937 and has fallen 94.1% since, to $114 in 2025. Among obstetrics & gynecology clinicians in NJ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 133 payments — averaging $36.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Celularity Inc.$3K
- AbbVie$305
- Daiichi Sankyo Inc.$208
- Coopersurgical, Inc.$175
- Bayer$166
- Mayne Pharma Commercial LLC$141
- plus $996 from 22 others
What the payments were for
- Speaking & faculty fees$2,80058%
- Food & beverage$1,94140%
- Education$651%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Celularity Inc. | 12 | $2,815 |
| AbbVie(2 entities) | 22 | $305 |
| Daiichi Sankyo Inc. | 15 | $208 |
| Coopersurgical, Inc. | 12 | $175 |
| Bayer | 4 | $166 |
| Mayne Pharma Commercial LLC | 13 | $141 |
| Hologic Sales And Service, LLC | 5 | $128 |
| Medtronic | 2 | $109 |
| Therapeuticsmd, Inc. | 7 | $105 |
| Avion Pharmaceuticals | 6 | $82 |
| Pfizer | 4 | $76 |
| Myovant Sciences Inc. | 3 | $50 |
| AMAG Pharmaceuticals, Inc. | 3 | $50 |
| Exeltis, USA Inc. | 3 | $45 |
| Astellas Pharma US Inc | 2 | $44 |
| Molnlycke Health Care US, LLC | 2 | $44 |
| Vertical Pharmaceuticals, LLC | 3 | $40 |
| Organon | 2 | $35 |
| Agile Therapeutics, Inc. | 2 | $30 |
| Amgen | 2 | $30 |
| Millicent US Inc | 2 | $26 |
| Roche Diagnostics Corporation | 1 | $20 |
| Meditrina | 1 | $15 |
| Sage Therapeutics, LLC | 1 | $15 |
| Sumitomo Pharma America, Inc. | 1 | $15 |
| Merck | 1 | $13 |
| Minerva Surgical, Inc | 1 | $13 |
| Duchesnay USA Incorporated | 1 | $12 |
How this compares
$4,805 in reported general payments places this provider in the 90th percentile of 1,242 obstetrics & gynecology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other obstetrics & gynecology in Morristown
- Patrick CulliganMorristown$93K
- Gregory HirschMorristown$27K
- Matthew IammatteoMorristown$26K
- Donia ShawMorristown$18K
- Sharon MassMorristown$7K
- Jennifer AshtonEnglewood$1.5M
- Geoffrey BowersVoorhees$228K
- Neha DeshpandePlainsboro$206K
- Paula JasionowskiVoorhees$193K
- Justin ChuraSwedesboro$179K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.